EGFR (Trans)activation Mediates IL-8 and Distinct Human Antimicrobial Peptide and Protein Production following Skin Injury  by Büchau, Amanda S.
commentary
 www.jidonline.org 929
See related article on pg 1167
EGFR (Trans)activation Mediates IL-8 
and Distinct Human Antimicrobial 
Peptide and Protein Production 
following Skin Injury
Amanda S. Büchau1,2
Antimicrobial peptides and proteins (AMPs) are tools of the innate immune sys-
tem employed at injury sites to protect the host from invading microbes and to 
promote wound repair. In this issue, Roupé et al. characterize epidermal innate 
immune responses induced by skin injury and the involvement of EGFR for 
distinct AMPs and IL-8 induction.
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cutaneous innate immune recognition 
and responses
The innate immune system relies on 
rapid recognition and defense mecha-
nisms to protect against microbial patho-
gens or injury. Sensing invading microbes 
based on their pathogen-associated 
molecular patterns is accomplished via 
pathogen recognition receptors, such 
as Toll-like receptors (TLRs). TLRs are 
structurally related to the Drosophila 
Toll receptor and are expressed in and 
on human keratinocytes (Büchau and 
Gallo, 2007). Antimicrobial peptides 
and proteins (AMPs) are effector mol-
ecules of the host defense repertoire. 
In addition to their microbicidal activ-
ity, AMPs have chemoattractive proper-
ties and display additional functions as 
proteinase inhibitors, proangiogenic 
molecules, and modulators of adaptive 
immunity. Interestingly, most features of 
classic host defense mechanisms against 
microbes also become activated follow-
ing skin injury.
The expression of AMPs differs 
depending on the cell type and tissue. 
More than 20 AMPs have been char-
acterized in skin, including human 
β-defensins (hBDs), cathelicidins, and 
several S100 proteins. In addition, 
elafin, Rnase 7, lactoferrin, secretory 
leukocyte peptidase inhibitor (SLPI), and 
others have been identified and have 
recently gained more attention. The 
induction of AMP expression involves 
diverse signaling pathways: In keratino-
cytes, hBD1 is expressed constitutively, 
whereas messenger RNA expression 
of hBD2, hBD3, and hBD4 requires 
TLR signaling or initiation through 
tumor necrosis factor (TNF)-α, IL-1β, 
or other cytokines (Büchau and Gallo, 
2007). hBD3 is upregulated by insulin-
like growth factor 1 and EGFR ligands 
(Sorensen et al., 2006). Transcription 
of human cathelicidin is mediated via 
vitamin D signaling (Wang et al., 2004; 
Schauber et al., 2007); however, epi-
genetic modulation (Schauber et al., 
2008), nuclear factor of activated T cells 
(Büchau et al., 2008), and Bcl-3 (B-cell 
leukemia gene 3; Büchau et al., 2009) 
provide additional transcriptional con-
trol. The antimicrobial proteins S100A7 
and S100A15, which are induced by 
TLR signaling (Büchau et al., 2007; 
Abtin et al., 2008), are inducible by dif-
ferentiation (Büchau and Gallo, 2007), 
whereas S100A8 and S100A9 are most 
likely regulated by the activation state 
of keratinocytes (Thorey et al., 2001). In 
addition to transcriptional regulation, 
posttranslational mechanisms, such as 
proteolytic processing from precursor 
proteins, provide complementary con-
trol of some AMPs.
Injury results from breaching of the 
skin barrier, and it induces a series of 
wound healing responses that are divid-
ed into phases (Figure 1). One mecha-
nism of first-line defense is an increase 
in AMPs at the wound bed and edges. 
AMPs not only exert direct antimicrobi-
al activity but also promote wound heal-
ing by several different mechanisms. For 
example, human cathelicidin LL-37 has 
angiogenic and chemoattractive func-
tions, and it exhibits antifibrotic effects 
through the suppression of collagen 
production (Büchau and Gallo, 2007; 
Park et al., 2009). hBD2 stimulates 
migration and proliferation of endothe-
lial cells, and it attracts CCR6+ immune 
cells (Yang et al., 1999). The report by 
Roupé et al. (2010, this issue) pro-
vides insight into the time-dependent 
induction of AMP transcription and pro-
tein expression in wounds. The authors 
report that elevated SLPI and elafin pro-
tein levels became apparent on day 2, 
with enhanced expression on days 3 
and 4 after skin injury, whereas hBD2 
protein levels are only weakly upregu-
lated at day 4. Of note, hBD2 transcript 
levels, based on microarray data (but 
not protein levels), are highly elevated 
on day 4 after wounding, suggesting 
that this antimicrobial peptide may be 
important for the later inflammatory 
phase of the wound healing responses 
(see Figure 1). cDNA microarray analy-
sis of wounds on day 4 after wounding 
further identifies upregulation of other 
antimicrobial peptide and protein genes 
(S100A7, S100A8, S100A9, S100A15, 
haptocorrin, and lactoferrin) (Roupé et 
al., 2010).
Innate immune responses are mediated 
by epidermal injury and  
immune cell infiltration
Within seconds of cutaneous injury, an 
immune cascade is initiated that leads 
to a local immune response and to the 
attraction of immune cells from the 
peripheral circulation (see Figure 1). 
In the early phase of inflammation, 
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platelets and neutrophils are the major 
population of infiltrating cells at 
wound sites, whereas macrophages 
predominate at the later inflammatory 
phase. Platelets, neutrophils, and mac-
rophages release a plethora of growth 
factors and cytokines that orchestrate 
the inflammatory response. In later 
phases, during wound repair, fibro-
blasts produce large amounts of col-
lagen. Even later, the wound healing 
process involves remodeling of the 
granulation tissue.
Epidermal injury on the one hand 
and the influx of immune cells into 
wound sites on the other are impor-
tant for inducing and sustaining innate 
immune responses. Accordingly, an 
increase in AMP transcription may result 
from skin injury or enhanced immune 
cell infiltration. Roupé et al. (2010) dis-
tinguished between these two events 
(skin injury versus immune cell infiltra-
tion), comparing in vivo wounds with 
ex vivo wounded skin, where immune 
cell infiltration from the periphery is 
largely absent. It appears that several 
AMPs that were significantly upregu-
lated in in vivo wounds were also sig-
nificantly increased in ex vivo wounds 
(Figure 2; hBD2, hBD3, S100A7 (pso-
riasin), S100A8 (calgranulin A), S100A9 
(calgranulin B), SLPI, and haptocorrin). 
However, expression levels of hBD2 and 
haptocorrin were much lower in the ex 
vivo model compared with the in vivo 
model, suggesting that skin injury alone 
is not the major inducer of these AMPs. 
S100A15 was highly elevated in in vivo 
wounds 4 days after skin injury, and this 
increase was absent in ex vivo wounds, 
suggesting that infiltrating inflamma-
tory cells highly affect its expression, 
either by expressing this AMP itself or by 
releasing factors that trigger S100A15 
induction in keratinocytes. RNAse7, 
in contrast, was almost absent in full-
thickness in vivo wound samples but 
Hemostasis and inflammatory phase
 (0–72 hours)
Within seconds of cutaneous injury, blood
vessels constrict to control bleeding at the
site. Platelets coalesce to stop the
bleeding and begin clot formation.
Neutrophils enter the wound to fight
infection, and macrophages are
subsequently attracted to the wound site.
Macrophages break down necrotic debris
and activate the fibroblast response.
   
On the surface of the wound, epidermal
cells start to proliferate and  begin their
migration across the surface of the
wound. Fibroblasts proliferate in the
deeper parts of the wound and
synthesize small amounts of collagen,
which act as  a  scaffold for  migration  and
further fibroblast proliferation.
Granulation tissue, which consists of
capillary loops supported in this
developing collagen matrix, also appears
in the deeper layers of the wound.
Remodeling and maturation phase
(2 weeks– several months)
Activated fibroblasts begin to produce
large amounts of collagen and
proteoglycans. Within 2–3 weeks, the
wound can resist normal stresses, but
wound strength continues to build for
several months. The fibroblastic phase
lasts from 15 to 20 days, and then wound
healing enters the maturation phase.
During the maturation phase, fibroblasts
leave the wound and collagen is
remodeled into a more organized matrix.
These processes to regain 70 to 80% of
Red blood cells
Platelets
Neutrophils
M
Fibroblasts
Collagen
Proliferation phase
(72 hours–2 weeks)
the tissue’s original strength last for up to
1 year following the injury.
Figure 1. Phases of wound healing. Once the skin barrier is disrupted, the normal process of wound 
healing is immediately initiated. The classic model of wound healing is divided into three to four 
sequential, yet overlapping, phases consisting of hemostasis and inflammatory phase, proliferation 
phase, and remodeling and maturation phase. MΦ, macrophage.
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Figure 2. Upregulation of distinct genes in in vivo and ex vivo wound healing models. Epidermal injury 
induces distinct human antimicrobial peptides and proteins (AMPs), epidermal growth factor receptor (EGFR) 
ligands, cytokines, and chemokines. In the in vivo model, reactive infiltration of immune cells is present and 
affects wound healing responses. Epidermal injury also induces a host immune response independent of 
infiltrating immune cells in the ex vivo model. AMP, antimicrobial peptides and proteins; HB-EGF, heparin-
binding epidermal growth factor; mRNA, messenger RNA; TGF-α, transforming growth factor-α.
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Antimicrobial peptides 
and proteins, tools of 
innate immunity, also 
have roles in wound 
healing.
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was increased in ex vivo established 
wounds, suggesting that its major source 
is resident cells of the skin. Furthermore, 
transcription of IL-6, IL-8, IL-20, IL-24, 
and CXCL1 was elevated in both in vivo 
and ex vivo wounds, with much higher 
levels in the ex vivo model. This result 
implies that resident cells are a rich 
source of the cytokines and chemokines 
important for neutrophil attraction and 
keratinocyte proliferation.
eGFr (trans)activation is involved in 
amP and chemokine induction
The EGFR signaling pathway is crucial 
for controlling survival, migration, and 
proliferation of cells, including kerati-
nocytes (Pastore et al., 2008). Epidermal 
keratinocytes express EGFR, which sta-
bilizes its own “steady-state” activation 
via an autocrine/paracrine feedback 
mechanism (Figure 3). Apart from direct 
activation by its specific ligands, EGFR 
activation is also induced via trans-
activation. Stimulation of G-coupled 
receptors and various cytokine recep-
tors promotes metalloproteinase-medi-
ated cleavage of mature forms of EGFR 
ligands. Earlier studies documented a 
role for EGFR in wound healing and in 
particular for hBD3 regulation (Sorensen 
et al., 2006). In this study, Roupe et al. 
demonstrate that further innate immune 
responses in wounds are indeed EGFR-
dependent. Roupé et al. show that inju-
ry-induced AMP expression in ex vivo 
wounds was suppressed by the pres-
ence of an EGFR inhibitor. Moreover, 
this effect was also observed for injury-
induced IL-6, IL-8, IL-20, IL-24, and 
CXCL1 expression. Not only were the 
neutrophil chemoattractants IL-8 and 
CXCL1 upregulated in in vivo and even 
stronger in ex vivo wounds, but their 
induction was mimicked by stimulating 
cultured keratinocytes with the EGFR 
ligand transforming growth factor-α. 
This finding was paralleled by the fact 
that supernatants from ex vivo injured 
skin exhibited chemoattractive activity 
toward neutrophils, an effect that was 
abolished by neutralizing IL-8 antibod-
ies and also suppressed by the pres-
ence of EGFR inhibitors during ex vivo 
wounding. However, antibodies neu-
tralizing CXCL1 during ex vivo wound-
ing did not inhibit chemotaxis toward 
neutrophils, demonstrating that CXCL1 
is not the major chemokine to attract 
neutrophils in this experimental setting.
Roupé et al. (2010) furthermore per-
formed mouse experiments confirm-
ing the important and inherent role of 
epidermal injury for AMP expression 
during wound healing independent of 
infection. However, they did not find 
EGFR-dependent production of cyto-
kines and AMPs in mice, in contrast 
to their findings in human skin. These 
findings suggest that other mechanisms 
initiate innate immune responses in 
rodents; such mechanisms should be 
identified in future studies.
In summary, Roupé et al. highlight 
the fact that epidermal injury is a potent 
inducer of distinct human antimicro-
bial peptide, cytokine, and chemokine 
production, independent of infiltrating 
immune cells. But questions remain. 
EGFR becomes activated within 30 
minutes after wounding, followed by a 
rapid IL-8 induction and a more gradual 
increase of AMPs (Roupé et al., 2010). 
Why is IL-8 induced before AMP produc-
tion to protect the host from pathogen 
entry and promote wound healing? Is it 
possible that other factors induce EGFR 
transactivation, which subsequently 
drives production of downstream genes? 
The authors have excluded the possibility 
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Figure 3. eGFr (trans)activation in keratinocytes. The epidermal growth factor receptor (EGFR) 
contributes to its own activation via an autocrine/paracrine feedback mechanism. Apart from direct 
activation by specific ligands, EGFR also becomes activated via transactivation. Stimulation of 
G-coupled receptors and certain cytokine receptors results in matrix metalloproteinase (MMP)-mediated 
shedding of EGFR ligands from membrane precursors, leading to transactivation of EGFR. Activated 
EGFR regulates transcription of downstream genes such as human β-defensin (hBD)-2 and -3, RNAse7, 
S100A7, elafin, and several cytokines and chemokines. HB-EGF, heparin-binding epidermal growth 
factor; TGF-α, transforming growth factor-α.
that IL-8 itself may play this role, but is 
it possible that other molecules leading 
to EGFR phosphorylation result in the 
production of EGFR-dependent AMPs? 
Which functions are fulfilled by the anti-
microbial peptides SLPI, elafin, and lac-
toferrin during wound healing?
The injury-induced epidermal 
immune response elicited by resident 
skin cells may involve multiple mol-
ecules. In addition to keratinocytes, 
other resident effector skin cells, includ-
ing dendritic epidermal T cells and 
mast cells, may confer host defense in 
very early stages after injury through 
un identified mechanisms. A fur-
ther wrinkle in the complex crosstalk 
between innate immune responses and 
EGFR-driven events is that cathelicidin 
LL-37, an AMP itself, can induce EGFR 
transactivation via a metalloproteinase-
dependent shedding of EGFR ligands 
(Tokumaru et al., 2005).
Analyzing these factors in depth may 
shed light on the tightly regulated pro-
cesses involved in host defense mecha-
nisms that lead to initiating, sustaining, 
and terminating inflammatory responses 
during wound healing.
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